An indeterminate (or equivocal) STD result means the lab couldn't sort your sample cleanly into positive or negative — it landed in a gray zone. It's neither a diagnosis nor an all-clear. The usual next step is a confirmatory test, a repeat draw, or retesting after the window period closes, depending on which infection it was.
| Item | Days after exposure |
|---|---|
| Chlamydia / gonorrhea (NAAT) | ~14 |
| HIV — NAT | 10–33 |
| HIV — antigen/antibody | 18–45 |
| HIV — rapid antibody | 23–90 |
What an indeterminate result actually is
STI tests don't read like a light switch. Each one measures a signal — genetic material, an antibody, an antigen — against a threshold the lab uses to call a result positive or negative. When your sample sits right at that cutoff, the analyzer can't commit, and the report comes back as indeterminate, equivocal, or borderline. A false positive or false negative gives a wrong but confident answer; here the test is telling you it doesn't know yet.
A few things can land you in that zone: an infection caught very early, when the signal is still climbing; a sample collected slightly too soon, contaminated, or degraded in transit; or, for antibody-based tests, lingering or cross-reacting antibodies from a past infection or another condition. Rather than guess which, you do the confirmatory step, which is built into the testing process for this reason.
How the test works — sample and method
Most STIs are tested from a simple sample. Chlamydia, gonorrhea, and trichomoniasis use a urine cup or a self-collected swab run through a NAAT (nucleic acid amplification test), which copies and detects the organism's genetic material. HIV, syphilis, and hepatitis use a blood draw CDC, HIV Testing. In practice it's a few minutes in the chair, and results come back in a day or a few.
NAATs are the most sensitive tests for chlamydia and gonorrhea, which is why guidelines recommend them; modern NAATs are highly accurate, with specificity around 99% CDC, Chlamydia Guidelines. High specificity means false positives are rare, but rare isn't never, so a borderline result gets a second look rather than an instant diagnosis. If you want to see exactly which infections a standard order covers (and which it quietly skips), here's what's actually in a 'full' std panel.
When to test after exposure — the window period
There's a gap between exposure and when a test can detect an infection, called the window period. Test inside that gap and you can get a falsely reassuring negative, or a borderline result, because the signal hasn't fully built. Timing is the single biggest factor people get wrong.
For HIV, the window depends on the test: a nucleic acid test (NAT) can detect infection about 10–33 days after exposure, an antigen/antibody lab test about 18–45 days, and a rapid antibody test about 23–90 days. For chlamydia and gonorrhea, a NAAT is generally reliable about two weeks after exposure; if you test sooner, repeating later is reasonable when a recent exposure is possible. If your indeterminate result came from an early test, the fix is often to wait and retest — here's a fuller guide to when to test after exposure.
Where to get tested and what it costs
Testing is widely available at doctors' offices, health departments, Planned Parenthood, and Title X family-planning clinics — often free or on an income-based sliding scale — plus at-home and self-collection kits. You're rarely far from low-cost care: the US has roughly 16,000 federally-funded community health centers and about 4,200 Title X clinics, on top of tens of thousands of other public STI clinics HRSA.
At-home kits are convenient and private, but the same window-period math applies — order and use one at the right time, not the day after a scare. When you're ready, you can get tested, and if you're weighing mail-in versus in-clinic options you can compare testing providers.
Reading your results and how accurate they are
Many STIs cause no symptoms, so the test is what tells you your status. Screening matters even when nothing's wrong, because silent chlamydia or gonorrhea only shows up when you test for it. When a result is borderline, the meaning depends entirely on which infection and which method produced it.
Two safeguards exist specifically to handle uncertain results. HIV and syphilis use a two-step process — an initial screening test, then a different confirmatory test — and the result isn't final until the confirmatory step agrees CDC, 2024. A reactive rapid HIV test, in particular, is a preliminary result that must be confirmed with a follow-up lab test before it counts as a diagnosis. A reactive or indeterminate first step is the system working as designed.
| Result on the report | What it means | Typical next step |
|---|---|---|
| Negative | No infection detected — reliable if you were past the window | None, unless tested too early |
| Indeterminate / equivocal | Signal sat at the cutoff; can't be called either way | Repeat sample or wait and retest |
| Reactive / preliminary positive (HIV, syphilis) | Screening step flagged it; not yet a diagnosis | Confirmatory lab test before anything is final |
| Confirmed positive | Screening and confirmatory tests agree | Treatment and partner notification |
Testing before the window closes is the main cause of a false negative: the test isn't broken, the infection just isn't detectable yet. A too-early negative, or a borderline one, should be repeated rather than trusted.
If a result comes back positive
A confirmed positive isn't an emergency, and the common bacterial STIs like chlamydia are curable with a short, standard course of medication. Don't start treatment off an indeterminate or preliminary result, though — wait for confirmation, then follow your clinician's plan.
When to see a clinician
Call a clinician if your result is indeterminate and you're not sure of the next step, if a rapid HIV or syphilis screen came back reactive, if you have symptoms, or if you had a known exposure to a partner who tested positive. A clinician can read the borderline number in context, order the right confirmatory test, and tell you when to retest based on your exposure date. The USPSTF recommends routine chlamydia and gonorrhea screening for sexually active people who meet risk criteria, so it's also worth asking whether you're due regardless of this one result USPSTF.